Abstract
Complement-mediated lysis of sheep erythrocytes coated with optimal concentrations of rabbit IgG hemolysin was inhibited by euglobulin fractions from the sera of patients with seropositive rheumatoid arthritis. That this was due to direct interaction with the IgG coat on the red cell rather than a nonspecific reaction with complement in the fluid phase was confirmed by controls using cells coated with IgM hemolysin. The inhibitory activity was recovered in purified IgM rheumatoid factor preparations and could be absorbed out with insoluble aggregated human IgG. The inhibitory potency of the rheumatoid factors correlated well with their sheep cell agglutination titers. Inhibition was not the result of physical aggregation of the erythrocytes by rheumatoid factor. Kinetic studies were consistent with the view that rheumatoid factor displaces C1q from its binding to IgG. Paradoxically, at suboptimal sensitizing concentrations of IgG hemolysin, rheumatoid factor enhances the fixation of complement. These results can be interpreted on the basis of the blockage of complement fixation by IgG and its replacement by a relatively weak direct fixation by the IgM rheumatoid factor. Thus, the interaction of RF with IgG generates only a limited ability to fix complement which, when contrasted with the fixation at suboptimal concentrations of IgG hemolysin alone, appears as net enhancement; when this is contrasted with fixation occurring with optimal concentrations of IgG, it appears as net inhibition.
Full Text
The Full Text of this article is available as a PDF (1.0 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUTLER V. P., Jr, VAUGHAN J. H. HEMAGGLUTINATION BY RHEUMATOID FACTOR OF CELLS COATED WITH ANIMAL GAMMA GLOBULINS. Proc Soc Exp Biol Med. 1964 Jul;116:585–593. doi: 10.3181/00379727-116-29313. [DOI] [PubMed] [Google Scholar]
- BUTLER V. P., Jr, VAUGHAN J. H. THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. Immunology. 1965 Feb;8:144–159. [PMC free article] [PubMed] [Google Scholar]
- Bienenstock J., Bloch K. J. Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis. Arthritis Rheum. 1967 Jun;10(3):187–198. doi: 10.1002/art.1780100304. [DOI] [PubMed] [Google Scholar]
- Borsos T., Rapp H. J. Complement fixation on cell surfaces by 19S and 7S antibodies. Science. 1965 Oct 22;150(3695):505–506. doi: 10.1126/science.150.3695.505. [DOI] [PubMed] [Google Scholar]
- Borsos T., Rapp H. J. Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J Immunol. 1965 Sep;95(3):559–566. [PubMed] [Google Scholar]
- CHRISTIAN C. L. THE RHEUMATOID FACTORS. J Chronic Dis. 1963 Aug;16:875–888. doi: 10.1016/0021-9681(63)90137-1. [DOI] [PubMed] [Google Scholar]
- Colten H. R., Borsos T., Rapp H. J. Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength. J Immunol. 1968 Apr;100(4):799–807. [PubMed] [Google Scholar]
- DAVIS J. S., 4th, BOLLET A. J. PROTECTION OF A COMPLEMENT-SENSITIVE ENZYME SYSTEM BY RHEUMATOID FACTOR. J Immunol. 1964 Jan;92:139–144. [PubMed] [Google Scholar]
- Gough W. W., Davis J. S., 4th Effects of rheumatoid factor on complement levels in vivo. Arthritis Rheum. 1966 Aug;9(4):555–565. doi: 10.1002/art.1780090402. [DOI] [PubMed] [Google Scholar]
- HEIMER R., LEVIN F. M., KAHN M. F. INHIBITION OF COMPLEMENT FIXATION BY HUMAN SERUM. II. THE ACTIVITY OF A GAMMA-LM GLOBULIN AND RHEUMATOID FACTOR IN COMPLEMENT FIXATION REACTIONS. J Immunol. 1963 Dec;91:866–872. [PubMed] [Google Scholar]
- KUNKEL H. G., TAN E. M. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. doi: 10.1016/s0065-2776(08)60711-7. [DOI] [PubMed] [Google Scholar]
- MORSE J. H., CHRISTIAN C. L. IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM. J Exp Med. 1964 Feb 1;119:195–209. doi: 10.1084/jem.119.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MULLER-EBERHARD H. J., KUNKEL H. G. Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis. Proc Soc Exp Biol Med. 1961 Feb;106:291–295. doi: 10.3181/00379727-106-26313. [DOI] [PubMed] [Google Scholar]
- McCormick J. N., Day J., Morris C. J., Hill A. G. The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis. Clin Exp Immunol. 1969 Jan;4(1):17–28. [PMC free article] [PubMed] [Google Scholar]
- PARKER R. L., SCHMID F. R. Phagocytosis of particulate complexes of gamma-globulin and rheumatoid factor. J Immunol. 1962 Apr;88:519–525. [PubMed] [Google Scholar]
- PEKIN T. J., Jr, ZVAIFLER N. J. HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID. J Clin Invest. 1964 Jul;43:1372–1382. doi: 10.1172/JCI105013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Romeyn J. A., Bowman D. M. Inhibition of complementary lysis by rheumatoid sera. Nature. 1967 Oct 14;216(5111):180–181. doi: 10.1038/216180a0. [DOI] [PubMed] [Google Scholar]
- Vaughan J. H., Jacox R. J., Noell P. Relation of intracytoplasmic inclusions in joint fluid leukocytes to anti-gamma-G globulins. Arthritis Rheum. 1968 Apr;11(2):135–144. doi: 10.1002/art.1780110203. [DOI] [PubMed] [Google Scholar]
- WAKSMAN B. H. A comparison of the von Krogh formula (logistic function) and the method of probits as applied to hemolysis by complement. J Immunol. 1949 Dec;63(4):409–414. [PubMed] [Google Scholar]
- Zvaifler N. J., Schur P. Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies. Arthritis Rheum. 1968 Aug;11(4):523–536. doi: 10.1002/art.1780110402. [DOI] [PubMed] [Google Scholar]